Monthly Archives: June 2019

Lafayette Nursing Home Abuse Lawyer Medical Review Panel Win Announced

Kenneth D. St. Pe’, APLC has won a medical review panel in the case of Shonna Roy Thibodeaux vs. Goden Age of Welsh, LLC. It highlights the skill and experience that clients will benefit from when getting in touch with the Lafayette firm.

Lafayette, United States – June 28, 2019 /PressCable/

Lafayette, Louisiana law firm, Kenneth D. St. Pé, APLC, specializing in nursing home abuse, have announced that they have won a medical review panel in the case of Shonna Roy Thibodeaux vs Goden Age of Welsh, LLC. The win highlights the professional skill and expertise that clients can expect when getting in touch with the law firm.

More information can be found at: https://stpelaw.com

The site explains that clients can get in touch with Kenneth D. St. Pé Professional Law Corporation if they have experienced harm or loss of life due to nursing home abuse or negligence.

As a top rated Louisiana personal injury attorney, the firm can help with all nursing home abuse cases, medical malpractice issues, workplace and vehicle accidents, and unpaid wages and hours cases.

One of the benefits of getting in touch with the expert law firm is that it can offer free and confidential consultations. This helps clients to learn how they can be impacted by the services provided.

Anyone who has themselves been seriously injured in an accident, or been the victim of a medical mistake is encouraged to get in touch with Kenneth D. St. Pé.

A full list of services is provided on the law firm website, and includes wage, hour and FLSA violations, offshore accidents, nursing home abuse, wrongful death, auto accidents, and medical malpractice.

Kenneth D. St. Pé is a board certified medical malpractice lawyer located in Lafayette, Louisiana. Clients getting in touch with his firm will benefit from his skill and experience in the areas of personal injury and medical malpractice.

The firm states: “If you have a loved one in a nursing home and you are concerned about neglect or abuse, we can help. If you or a loved one was injured in a motorcycle accident or 18-wheeler wreck or car accident, we will fight for fair compensation. The hallmark of Kenneth D. St.Pe’ and his practice is the exceptional personal service he provides for his clients.”

Full details of the services provided can be found on the URL above.

Contact Info:
Name: Kenneth D. St. Pe’
Email: Send Email
Organization: Kenneth D. St. Pe’, APLC
Address: 311 W University Ave, Lafayette, Louisiana 70506, United States
Phone: +1-337-534-4043
Website: https://stpelaw.com

Source: PressCable

Release ID: 88890721

Hemogenyx Pharmaceuticals PLC announces Result of AGM

Result of Annual General Meeting

LONDON, UK / ACCESSWIRE / June 28, 2019 / The Annual General Meeting of Hemogenyx Pharmaceuticals plc was held at the offices of Osborne Clarke LLP, One London Wall, London EC2Y 5EB on Friday 28 June 2019 at 11.00 am.

Voting on all of the resolutions was conducted on a show of hands. All resolutions were passed. The full text of each of the resolutions is set out in the notice of the meeting, which is available on the Company’s website at https://www.hemogenyx.com/investors/default.aspx.

The numbers of proxy votes duly lodged prior to the meeting are set out below and will also be available on the Company’s website at https://www.hemogenyx.com/investors/default.aspx.

Proxy Votes duly lodged prior to the meeting

Ordinary
Resolutions

Votes for

% of votes cast for

Votes Against

% of votes cast against

Total votes cast

Total votes cast as % of ISC(1)

Votes withheld

To approve the Company’s annual accounts for the financial year ended 31 December 2018

119,390,068

100%

0

N/A

119,390,068

33.1%

0

To approve the directors’ remuneration report contained within the annual report and accounts for the financial year ended 31 December 2018

119,386,946

100%

0

N/A

119,386,946

33.1%

3,122

To re-appoint PKF Littlejohn LLP as auditor of the Company

119,261,281

100%

0

N/A

119,261,281

33.1%

128,787

To authorise the directors to determine the level of the auditor’s remuneration

119,386,946

100%

0

N/A

119,386,946

33.1%

3,122

To provide the directors with authority to allot ordinary shares

119,386,946

100%

0

N/A

119,386,946

33.1%

3,122

Special Resolutions

Votes for

% of votes cast for

Votes against

% of votes cast against

Total votes cast

Total votes cast as % of ISC(1)

Votes withheld

To disapply statutory pre-emption rights

119,258,159

100%

0

N/A

119,258,159

33.1%

131,909

(1) The Company’s issued share capital (ISC) on 28 May 2019, being the date on which members had to be entered in the register of members of the Company in order to be entitled to attend and vote at the meeting, was 360,176,186 ordinary shares.

(2) A ‘vote withheld’ in respect of any resolution is not a vote in law and is not counted in the calculation of the proportion of the votes for and against it.

Enquiries:

Hemogenyx Pharmaceuticals plc

www.hemogenyx.com

Dr Vladislav Sandler, Chief Executive Officer & Co-Founder

headquarters@hemogenyx.com

Sir Marc Feldmann, Chairman

SP Angel Corporate Finance LLP

Tel: +44 (0)20 3470 0470

Matthew Johnson, Vadim Alexandre, Soltan Tagiev

Peterhouse Corporate Finance
Limited

Tel: +44 (0)20 7469 0930

Lucy Williams, Duncan Vasey

US Media enquiries

Tel: +1 (323) 646-3249

Lowell Goodman

lowell@corbomitecomms.com

About Hemogenyx
Pharmaceuticals plc

Hemogenyx Pharmaceuticals plc (“Hemogenyx”) is a publicly traded company (LSE: HEMO) headquartered in London, with its wholly-owned US operating subsidiaries, Hemogenyx LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility and a wholly-owned Belgian operating subsidiary, Hemogenyx-Cell SPRL, located in Liège.

Hemogenyx is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. Hemogenyx is developing two distinct and complementary products, as well as a platform technology that it uses as an engine for novel product development.

For more than 50 years, bone marrow transplantation has been used to save the lives of patients suffering from blood diseases. The risks of toxicity and death that are associated with bone marrow transplantation, however, have meant that the procedure is restricted to use only as a last resort. Hemogenyx’s technology has the potential to enable many more patients suffering from devastating blood diseases such as leukemia and lymphoma, as well as severe autoimmune diseases such as multiple sclerosis, aplastic anemia and systemic lupus erythematosus (Lupus), to benefit from bone marrow transplantation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Hemogenyx Pharmaceuticals plc

ReleaseID: 550246

Jerash Reports Record Fourth Quarter, Full Year Revenue in Fiscal 2019

Positioned for Expected Further Revenue Growth in Fiscal 2020

ROCHESTER, NY / ACCESSWIRE / June 28, 2019 / Jerash Holdings (US), Inc. (Nasdaq: JRSH) (the “Company” or “Jerash”), a producer of high-quality textile goods for leading global brands, today reported record revenue for its fiscal 2019 fourth quarter and full year ended March 31, 2019.

Fiscal Year 2019 and Recent Highlights

Reported record revenue of $85.0 million in fiscal 2019, an increase of 23% versus $69.3 million in fiscal 2018;
Generated gross margin of 22.1% in fiscal 2019 as the Company commenced production with multiple new customers and products to diversify market share;
Reported GAAP net income of $5.1 million, or $0.45 per diluted share;
Generated adjusted EBITDA of $11.3 million, or $1.01 per diluted share;
Grew cash and cash equivalents to $27.8 million at year end;
Commenced production in April 2019 at a fourth manufacturing facility expected to add 1.5 million to 1.8 million pieces per year, bringing Jerash’s annual capacity to more than 8.0 million pieces, an anticipated increase of up to 27% annually; and
Positioned the Company for expected sustainable growth in revenue and GAAP net income through a focus on organic growth, strategic acquisitions and continued operating efficiency.

Fiscal Fourth Quarter 2019 Highlights

Revenue increased 64% to a record $14.5 million in the fourth quarter of fiscal 2019, from $8.9 million in the prior year fourth quarter, reflecting increased demand from existing customers;
Generated gross margins of 17.7% related to multiple sample orders from new potential customers expected to increase production with Jerash in the fiscal year ending March 31, 2020 (“fiscal 2020”);
Reported a GAAP net loss of $232,000, or $0.02 per diluted share, for the quarter, compared with net loss of $985,000, or $0.10 per basic share, in the prior year fourth quarter; and
Generated quarterly adjusted EBITDA1 of $286,000, or $0.03 per diluted share.

Management Commentary

Sam Choi, Chairman and Chief Executive Officer, stated: “We are pleased to report 23% sales growth in fiscal 2019 and record full-year revenue of $85.0 million. We also reported record fourth quarter revenue, increasing 64% to $14.5 million, as we continue to ramp second-half production volume with a number of new potential customers as part of our long-term growth strategy.

“We are particularly excited about a number of sample orders with new potential customers who are already indicating large volumes for the year ahead so as to take advantage of the increased capacity at our fourth factory facility, which we believe is now fully booked for fiscal 2020. We are making notable progress on our goal to increase second half production in order to maximize revenue from Jerash’s production facilities, as well as our efforts to further diversify our customer base and product categories.

“Finally, we are excited as we move into fiscal 2020 with expanded capacity, greater customer orders and a strong platform on which to further build our business for the benefit of our shareholders. We are providing an initial outlook for total revenue in excess of $100 million in fiscal 2020, which includes the ramping process for our new facility, and plan to continue in our efforts to accelerate our growth through strategic acquisitions that meet our stringent criteria for growth and profitability.”

Outlook

For fiscal 2020, Jerash anticipates continued revenue growth through both expanding business with existing customers and the addition of new customers. Total revenues for fiscal 2020 are projected to be in excess of $100 million, representing what is expected to be at least 17% organic growth over fiscal 2019.

Full Year Financial Results

For the full fiscal year 2019, Jerash reported total revenue of $85.0 million, an increase of 23% from $69.3 million in fiscal 2018. The increase in revenue reflected steady growth of sales from major customers and the addition of new potential customers. Gross margin in fiscal 2019 was 22.1%, compared with 25.9% in fiscal 2018. The change in gross margin includes the effect of share gain programs and sample orders from multiple new potential customers and categories in the second half of fiscal 2019.

Operating expenses for fiscal 2019 were $12.4 million, compared with $6.1 million in fiscal 2018. Operating expenses increased due to increased production, public company expenses following the Company’s May 2018 initial public offering (the “IPO”), and $3.6 million in stock-based compensation associated with the IPO.

Operating income for fiscal 2019 was $6.3 million.

GAAP net income for fiscal 2019 was $5.1 million, or $0.45 per diluted share, based on approximately 11.3 million shares outstanding.

Adjusted EBITDA1 for fiscal 2019 was $11.3 million, or $1.01 per diluted share. A reconciliation of adjusted EBITDA to GAAP net income is provided in the tables in this press release.

Fiscal 2018 Fourth Quarter Financial Results

Jerash reported revenue of $14.5 million for the fiscal fourth quarter ended March 31, 2019, a 64% increase from $8.9 million in the prior year fourth quarter. Revenue reflected growth in customer demand for warmer season goods as well as the addition of multiple new potential customers and expansion of orders with existing customers. Operating expenses were $2.8 million for the fiscal fourth quarter, reflecting additional payroll costs for increased headcount to drive revenue growth and public company expenses.

For the quarter, Jerash reported a GAAP net loss of $232,000, or $0.02 per share, compared to net loss of $1.0 million, or $0.10 per share, in the prior year fourth quarter.

Balance Sheet, Cash Flow and Dividends

Cash and restricted cash at March 31, 2019 was $27.8 million, compared with $12.2 million at March 31, 2018. As of March 31, 2019, inventory was $21.1 million, primarily comprised of fabric, work in progress and finished garments, and accounts receivable were $4.0 million. Jerash generated $9.8 million in cash flow from operations in fiscal 2019 and approved its first two quarterly dividends to shareholders.

Conference Call

The Company will conduct a conference call and webcast to review its fiscal 2019 results on Friday, June 28, 2019, at 9:00 a.m. ET. Interested parties in the United States can access the call by dialing 844-369-8770; interested parties outside the United States can access the call by dialing +1-862-298-0840. Callers should dial in at least 5 minutes prior to the all start time. A live and archived webcast will be available online in the investor relations section of Jerash’s website at www.jerashholdings.com. A replay of the conference call will be available until July 5, 2019, by calling 877-481-4010 from the United States or +1-919-882-2331 from outside the United States and entering conference ID number 49578.

About Jerash Holdings (US), Inc.

Jerash Holdings (US), Inc. (Nasdaq: JRSH) is a manufacturer utilized by many well-known brands and retailers, such as Walmart, Costco, Hanes, Columbia, VF Corporation (which owns brands such as The North Face, Timberland, Jansport, etc.), and PVH Corp. (which owns brands such as Calvin Klein, Tommy Hilfiger, IZOD, Speedo, etc.). Its production facilities are currently made up of four factory units and three warehouses and currently employ approximately 3,600 people. The total annual capacity at its facilities is expected to be approximately 8.0 million pieces by the end of calendar year 2019. Additional information is available at http://www.jerashholdings.com.

Non-GAAP Financial Information

This news release contains disclosure regarding adjusted EBITDA, which is determined by a method other than in accordance with U.S. GAAP. Adjusted EBITDA may help investors analyze our net income without regard to the effect of one-time stock-based compensation and before the effect of interest expenses, income taxes, and depreciation and amortization. Non-GAAP financial measures have inherent limitations and are not uniformly applied by issuers. Therefore, this non-GAAP financial measure should not be considered in isolation, or as a substitute for comparable measures prepared in accordance with GAAP. The comparable GAAP financial measures and reconciliation to the comparable GAAP financial measures can be found in Appendix A to this document.

Forward Looking Statements

This news release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements reflect Jerash’s current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including those risks described from time to time in filings made by Jerash with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated or expected. Statements contained in this news release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Jerash does not intend and does not assume any obligation to update these forward-looking statements, other than as required by law.

Contact:

Richard J. Shaw, Chief Financial Officer
(315) 727-6791
richard.shaw@jerashholdings.com


Matt Kreps, Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

1 Adjusted EBITDA is not a United States generally accepted accounting principles (“GAAP”) measure. A reconciliation of GAAP to non-GAAP measures is provided in the tables accompanying this release.

JERASH HOLDINGS (US), INC.,

SUBSIDIARIES AND AFFILIATE

CONSOLIDATED BALANCE SHEETS

March 31,

2019

2018

ASSETS

Current Assets:

Cash

$
27,182,158

$
8,597,830

Accounts receivable

4,020,369

5,247,090

Accounts receivable- related party

50,027

Inventories

21,074,243

20,293,392

Prepaid expenses and other current assets

2,630,727

1,533,868

Advance to suppliers

443,395

1,128,079

Total Current Assets

55,350,892

36,850,286

Restricted cash

652,310

3,598,280

Long-term deposits

810,172

Deferred tax assets

81,461

Property, plant and equipment, net

2,356,262

2,819,715

Total Assets

$
59,251,097

$
43,268,281

LIABILITIES AND EQUITY

Current Liabilities:

Credit facilities

$
648,711

$
980,195

Accounts payable

3,378,258

4,776,812

Accrued expenses

1,539,147

1,175,427

Income tax payable

1,164,238

112,000

Other payables

855,527

878,987

Total Current Liabilities

7,585,881

7,923,421

Income tax payable – non-current

1,403,087

1,288,000

Total Liabilities

8,988,968

9,211,421

Commitments and Contingencies (See Note 13)

Equity

Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding

$

$

Common stock, $0.001 par value; 30,000,000 and 15,000,000 shares authorized;11,325,000 shares and 9,895,000 shares issued and outstanding as of March 31, 2019 and March 31, 2018, respectively.

11,325

9,895

Additional paid-in capital

14,956,767

2,742,158

Statutory reserve

212,739

71,699

Retained earnings

34,786,735

30,948,006

Accumulated other comprehensive loss

(14,440
)

(24,502

Total Jerash Holdings (US), Inc.’s Shareholders’ Equity

49,953,126

33,747,256

Noncontrolling interest

309,003

309,604

Total Equity

50,262,129

34,056,860

Total Liabilities and Equity

$
59,251,097

$
43,268,281

JERASH HOLDINGS (US), INC.,

SUBSIDIARIES AND AFFILIATE

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

For the Years Ended March 31,

2019

2018

Revenue, net

$
84,983,661

$
69,295,698

Cost of goods sold

66,206,652

51,342,020

Gross Profit

18,777,009

17,953,678

Selling, general and administrative expenses

8,834,547

6,002,452

Share-based compensation expenses

3,593,888

116,578

Total Operating Expenses

12,428,435

6,119,030

Income from Operations

6,348,574

11,834,648

Other Income / (Expense):

Other income / (expense), net

23,802

(31,369
)

Total other income / (expense), net

23,802

(31,369
)

Net Income before provision for income taxes

6,372,376

11,803,279

Income tax expense

1,260,861

1,400,000

Net Income

5,111,515

10,403,279

Net loss attributable to noncontrolling interest

754

6,838

Net income attributable to Jerash Holdings (US), Inc.’s

Common Shareholders

$
5,112,269

10,410,117

Net Income

$
5,111,515

$
10,403,279

Other Comprehensive Income / (Loss):

Foreign currency translation gain / (loss)

10,215

(16,262
)

Total Comprehensive Income

5,121,730

10,387,017

Comprehensive loss attributable to noncontrolling interest

601

6,993

Comprehensive Income Attributable to Jerash Holdings (US), Inc.’s Common Shareholders

$
5,122,331

$
10,394,010

Earnings Per Share Attributable to Common Shareholders:

Basic

$
0.46

$
1.07

Diluted

$
0.45

$
1.07

Weighted Average Number of Shares

Basic

11,199,630

9,735,651

Diluted

11,330,310

9,735,651

JERASH HOLDINGS (US), INC.,
SUBSIDIARIES AND AFFILIATE
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

For the Quarters Ended March 31,

2019

2018

Revenue, net

$
14,479,015

$
8,852,298

Cost of goods sold

11,910,408

6,718,360

Gross Profit

2,568,607

2,133,938

Selling, general and administrative expenses

2,584,443

2,133,938

Share-based compensation expenses

193,954

0

Total Operating Expenses

2,778,397

1,685,928

Income from Operations

(209,790
)

448,010

Other Income / (Expense):

Other income / (expense), net

4,169

(32,685
)

Total other income / (expense), net

4,169

(32,685
)

Net Income before provision for income taxes

(205,621
)

415,325

Income tax expense

9,861

1,400,000

Net Income

(215,482
)

(984,675
)

Net loss attributable to noncontrolling interest

8

3,993

Net income (loss) attributable to Jerash Holdings (US), Inc.’s

Common Shareholders

$
(215,474
)

(980,682
)

Net Income

$
(215,482
)

$
(984,675
)

Other Comprehensive Income / (Loss):

Foreign currency translation gain / (loss)

124

14,011

Total Comprehensive Income

(215,358
)

(970,664
)

Comprehensive loss attributable to noncontrolling interest

9

3,858

Comprehensive Income Attributable to Jerash Holdings (US), Inc.’s Common Shareholders

$
(215,349
)

$
(966,806
)

Earnings Per Share Attributable to Common Shareholders:

Basic

$
(0.02
)

$
(0.11
)

Diluted

$
(0.02
)

$
(0.11
)

Weighted Average Number of Shares

Basic

11,199,630

9,735,651

Diluted

11,330,310

9,735,651

JERASH HOLDINGS (US), INC.,
SUBSIDIARIES AND AFFILIATE
CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended March 31,

2019

2018

CASH FLOWS FROM OPERATING ACTIVITIES

Net income

$

5,111,515

$

10,403,279

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

1,255,820

1,216,973

Share-based compensation expense

3,593,888

116,578

Changes in operating assets:

Accounts receivable

1,229,239

(2,472,680

)

Account receivable – related party

50,047

2,293,190

Inventories

(770,720

)

(1,151,531

)

Prepaid expenses and other current assets

(1,404,198

)

(470,441

)

Advances to suppliers

685,197

(1,128,320

)

Deferred tax assets

(81,461

)

Changes in operating liabilities:

Accounts payable

(1,400,533

)

(5,472,312

)

Accrued expenses

363,037

711,332

Other payables

(23,888

)

(282,472

)

Income tax payable

1,167,322

1,400,000

Net cash provided by operating activities

9,775,265

5,163,596

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property, plant and equipment

(791,001

)

(877,944

)

Acquisition deposit

(380,000

)

Long-term deposits

(430,113

)

Due from related party

336,746

Net cash used in investing activities

(1,601,114

)

(541,198

)

CASH FLOWS FROM FINANCING ACTIVITIES

Dividend distribution

(1,132,500

)

Proceeds (repay) from short-term loan

(331,876

)

980,403

Due from shareholders

692,500

Net proceeds from issuance of common stock

8,930,300

Warrants issued to the underwriter

30

Net proceeds from private placement

1,772,845

Net cash provided by financing activities

7,465,954

3,445,748

EFFECT OF EXCHANGE RATES CHANGES ON CASH

(1,747

)

(4,797

)

NET INCREASE IN CASH

15,638,358

8,063,349

CASH, AND RESTRICTED CASH, BEGINNING OF THE YEAR

12,196,110

4,132,761

CASH, AND RESTRICTED CASH, END OF THE YEAR

$

27,834,468

$

12,196,110

CASH, AND RESTRICTED CASH, END OF THE YEAR

27,834,468

12,196,110

LESS: NON-CURRENT RESTRICTED CASH

652,310

3,598,280

CASH, END OF PERIOD

$

27,182,158

$

8,597,830

Supplemental disclosure information:

Cash paid for income tax

$

175,000

$

Cash paid for interest

$

90,867

$

27,292

Non-cash financing activities:

Warrants issued to underwriters in connection with the IPO in fiscal 2019 and placement agent in connection with the private placement in fiscal 2018

$

160,732

$

161,926

Prepaid stock issuance cost netted with proceeds from the IPO in fiscal 2019 and the private placement in fiscal 2018

$

308,179

$

239,105

APPENDIX A – Reconciliation of Non-GAAP Financial Measures
JERASH HOLDINGS (US), INC.,
SUBSIDIARIES AND AFFILIATE
RECONCILIATION OF ADJUSTED EBITDA AND PER SHARE AMOUNTS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

Year Ended March, 31

2019

2018

Net income (loss)

$
5,112

$
10,403

Income taxes

1,261

1,400

Interest expense

91

27

Depreciation and amortization

1,256

1,217

Stock-based compensation expense

3,594

117

Adjusted EBITDA

$
11,314

$
13,164

Adjusted EBITDA Per Share

Basic

$
1.01

$
1.35

Diluted

$
1.00

$
1.35

Weighted Average Number of Shares

Basic

11,200

9,736

Diluted

11,330

9,736

Quarter Ended March, 31

2019

2018

Net income (loss)

$
(215
)

$
(985
)

Income taxes

10

1,400

Interest expense

1

23

Depreciation and amortization

296

318

Stock-based compensation expense

194

0

Adjusted EBITDA

$
286

$
756

Adjusted EBITDA Per Share

Basic

$
0.03

$
0.08

Diluted

$
0.03

$
0.08

Weighted Average Number of Shares

Basic

11,200

9,736

Diluted

11,330

9,736

SOURCE: Jerash Holdings (US), Inc.

ReleaseID: 550202

Condo Development to Host International Sports Meet

Tampines, Singapore – A condominium development at Tampines is set to host more than 800 sports representative from all over the world in the very first annual International Sports Meet.

Singapore, Singapore – June 28, 2019 /MarketersMedia/

Condo Development to Host International Sports Meet

Tampines, Singapore – A condominium development at Tampines is set to host more than 800 sports representative from all over the world in the very first annual International Sports Meet.

The condo complex is considered as the biggest development launch this year and it is developed by the Sim Lian Group, which is a highly-prestigious and trusted real estate and architecture company holdings in Singapore.

In a developing story reported by Alibaba Printing, the said Sim Lian condo is set to open 80 units for accommodation for the sports players and organizers. The event is to be held this November, but exact dates are yet to be announced. The said sports event will be hosted by prime sportscaster Henry Lee and well-known host and anchor Karen Uy.

The condominium complex is a massive development that is the size of 11 football fields. It has a total of 2,203 units divided in twenty-nine blocks of 12 stories each. The property investment said in its website, https://treasuretampinesofficial.com.sg/, that the first annual sports event will take place here in Singapore and they will be one of the major sponsors, along with several other Singapore-based companies, schools, and shopping centres.

In the said statement, the company’s spokesperson said that they are happy and proud to announce that they will be sponsoring the upcoming event and probably every year after that for the next five years or so.

For more information about this, please visit their website or see print ads or flyers for more details.

Contact Info:
Name: Chris
Email: Send Email
Organization: Flyer distribution Sg – Alibaba Printing
Address: Link@Amk, 3 Ang Mo Kio Street 62, 02-02, 569139
Phone: 9146 1431
Website: http://alibabaprinting.sg/blog

Source URL: https://marketersmedia.com/condo-development-to-host-international-sports-meet/88890790

Source: MarketersMedia

Release ID: 88890790

Leading Cleveland Criminal Attorney Edward R. La Rue Gets Drug Charges Dropped for First-Time Possession Offense

Criminal attorney Edward La Rue, founding partner at the Law Office of Edward La Rue in Cleveland, OH, explains how it’s possible to get drug charges dropped after already pleading guilty to a first-time possession offense. For more information please visit www.edwardrlarue.com

Cleveland, OH, United States – June 28, 2019 /MM-REB/

In a recent interview, leading criminal attorney Edward La Rue, founding partner at the Law Office of Edward R. La Rue in Cleveland, OH, revealed that he was able to get drug charges dropped for a first-time possession offense in a number of different ways.

For more information please visit http://www.edwardrlarue.com

When asked to comment, La Rue stated, “Punishment for first-time drug possession offenders is often quite harsh, particularly for those with a great deal to lose – on top of that, a criminal conviction can leave a potentially permanent stain on your record.”

However, La Rue said, there are ways to get clients cleared of their original charge, even, in some cases, when they have already pleaded guilty to a first-time possession offense.

When asked to elaborate, he said, “In a previous case, two people who had pleaded guilty to a first-time possession offence were placed on probation, and their adjudication of guilt was withheld, which meant they didn’t receive a criminal conviction. However, when they violated the terms of their probation, they both faced jail and prison time.”

If not careful, La Rue was quick to add, it’s quite easy to violate probation terms.

“It was at this point that I was hired to represent them, and I quickly realized that there were issues with how the police conducted searches in each of their cases. Because of this discovery, the pleas, sentences, and convictions in both cases were overturned, and the initial charges were dismissed,” he said.

According to La Rue, criminal defense attorneys in Ohio often get their clients to plead guilty to possession charges, particularly when it comes to marijuana and cocaine, due to severe punishment for possession compared to the relative ease of proving a client’s possession of such drugs in many instances.

In the state of Ohio, being in possession of only small amounts of prescription pills, heroin, methamphetamine, LSD, cocaine, and countless other party drugs is considered a felony and carries a sentence of up to a year in a state institution, and/or five years of probation/supervision. Worse still are the collateral impacts of such consequences upon personal relationships, finances, career, personal and real property, missing important events, etc.

“Many people agree to these terms in order to get a reduced sentence or to be put on probation. But my experience proves that this is often not the way to go. Many also assume there are no other options aside from pleading guilty – but there often are in such cases. Speak with a seasoned criminal defense attorney to explore all your options before entering a guilty plea,” La Rue said.

Contact Info:
Name: Edward R. La Rue
Email: Send Email
Organization: Edward R. La Rue
Address: 820 W Superior Ave #840, Cleveland, OH 44113, USA
Phone: 216-696-8995
Website: http://www.edwardrlarue.com

Source: MM-REB

Release ID: 88889792

Featured Property: Gorgeous 4 BR Daphne Home Located In Great Neighborhood

Upon stepping into the foyer at 9823 Evanston Street, the soaring ceilings in this gorgeous home will take any visitor’s breath away.

Hawthorne, United States – June 28, 2019 /PressCable/

DAPHNE – Upon stepping into the foyer at 9823 Evanston Street, the soaring ceilings in this gorgeous home will take any visitor’s breath away.

This four-bedroom, three-bathroom home was built in 2008. Located to the right of the foyer is an open formal dining room. The great room contains a gas log fireplace that provides a way to warm up on the chilly nights.

The large chefs’ kitchen features granite counters, stainless steel appliances, including a Bosch gas range. The adjacent breakfast area offers a beautiful place to keep the cook company as they prepare meals. To the right of the kitchen is an in-law-suite with an attached bath.

Located on the other side of the house, the master bedroom is large enough for a sitting area or writing table. Included in the master bath is a tile shower, a jetted tub and a granite counter with double sinks. Along with another bedroom and bathroom, a large recreation room can be found upstairs.

The neighborhood offers many great amenities, including a resort-style swimming pool, clubhouse and lake.

More information, along with photos of the property, can be found through its website at https://www.mydaphnerealestate.com/property/285318/. A video of the property can be viewed here: https://www.tourfactory.com/yt2609769.

“This property offers a number of things that make this the ideal home in the eyes of many,” said Barbara Reeves, the property’s listing realtor. “I am excited to find the perfect buyer and pair them with their dream home because this listing is a great deal that will pay dividends for years to come.”

With a listing price of $339,000, the property can also be found on the MLS under the code, 285318.

Licensed as a real estate agent in 1998, Barbara Reeves has sold over $80+ Million in volume in the Mobile, Daphne, Fairhope, and Clarke County areas through the end of 2016. Having earned a RE/MAX Hall of Fame Award, Reeves loves putting her designation as a Certified New Home Specialist to work assisting buyers with new homes in Mobile Metro Area, Daphne, Fairhope & Eastern Shore, AL. Reeves’ slogan is “First Class Real Estate Services With Integrity & a Smile!”

For additional information on the property or to express interest, contact Barbara Reeves via call or text at 251-510-0629.

Contact Info:
Name: Michael Sneddon
Email: Send Email
Organization: Highlighted Homes
Address: 3501 Jack Northrop Ave Suite #AGQ146, Hawthorne, CA 90250, United States
Website: https://www.highlightedhomes.com/

Source: PressCable

Release ID: 88890693

Antiglare Glass Market: Statistics by 2019-2025, Top Trends & Growth Drivers

Antiglare Glass Market has several competitors with the development of innovative products. Some of the notable companies are Essilor International, Janos Technology LLC, Carl Zeiss AG, PPG Industries Inc., Honeywell International Inc., Optical Coatings Japan along with many more.

Selbyville, United States – June 28, 2019 /MarketersMedia/

Antiglare Glass Market size will see a significant growth from 2016 to 2024. This glass has a special coating to prevent reflections. It finds application in prescription eyewear, sunglasses, screens of electronic gadgets and even in the construction purposes. Increasing demand of stylish sunglasses and electronic gadgets will drive the market for antiglare glass in the forecast period.

Global antiglare glass market size will be propelled by the growing market of sunglasses. With growing awareness about the harmful UV rays from the sun and optical safety, the demand for sunglasses is expected to rise in the forecast period. Also, the demand of fashionable sunglasses has seen a healthy growth with the upgradation of the social status and enhancement of lifestyles.

Request for In-Depth Table of Content of this Report @ https://www.gminsights.com/request-toc/upcoming/820

Escalating demand of electronic devices and gadgets will also propel the antiglare glass market from 2016 to 2024. Advent of the digital age has shown a considerable increase in the demand of electronic gadgets. The number of smartphones user was over 2 billion in 2015 and is expected to cross 6 billion by 2020. The usage of antiglare glass for the mobile phone and computer screens will have a positive impact on the product market in the forecast period.

The antiglare glass market will see a substantial with the rise of conglomerates. Most commercial skyscrapers are designed with antiglare glass external walls and windows. The upcoming demand of skyscrapers in the emerging nations will positively affect the market from2016 to 2024.

The Antiglare Glass Market reports basic table of content consists of,
1. Methodology and Scope
2. Executive Summary
3. Antiglare Glass Market Industry Insights
3.1 Industry segmentation
3.2. Industry size, forecast and growth expectations, 2019 – 2025
3.3. Industry ecosystem analysis
3.4. Raw material insights
3.5. Technology insights
3.6. Regulatory framework
3.7. Industry dynamics
3.8. Key growth opportunities
3.9. Porter’s analysis
3.10. Company market share, 2018
3.11. PESTEL analysis
3.14. Regional price trends
4. Antiglare Glass Market Product Insights
5. Antiglare Glass Market Application Insights
6. Antiglare Glass Market Regional Insights
7. Competitor Profiles

Get More Details @ https://www.gminsights.com/industry-analysis/antiglare-glass-market

Based on applications, antiglare glass market share has two major types. The first application sector is optical lenses that are used in optometry as well as photography. They provide better quality images by reducing the distortion due to reflection. With growing demand of prescription eyewear and sunglasses, the antiglare optical lenses will have an escalating demand from 2016 to 2024. Also, with the growing popularity of social media, the demand for good quality camera and camera smartphones will grow healthily. This will propel the antiglare glass market in the forecast timeframe.

The second application sector for antiglare glass is in flat glass. This finds further use in buildings to reduce reflection off the window glass. Antiglare flat glass is also used in making the screens of electronic devices like computers, phones and e-book readers to reduce their harmful effects on human eyes. Another use of antireflective flat glass is in photolithography to reduce the image distortions off the surface of the substrate.
1 Antiglare Glass Market size & share forecast by product & application 2019-2025
2. Growth drivers, pitfalls & industry challenges
3. Antiglare Glass Market growth opportunities & emerging business models
4. Competitive benchmarking with market share analysis and company profiles

Make Customization in This Report @ https://www.gminsights.com/roc/820

The market has several competitors with the development of innovative products. Some of the notable companies are Essilor International, Janos Technology LLC, Carl Zeiss AG, PPG Industries Inc., Honeywell International Inc., Optical Coatings Japan along with many more. Essilor’s Crizal antiglare glass has an extensive use in eyewear. PPG Industries have Solarphire as a high transmissivity solar glass.

Contact Info:
Name: Arun Hedge
Email: Send Email
Organization: Global Market Insights, Inc.
Website: https://www.gminsights.com/industry-analysis/antiglare-glass-market

Source URL: https://marketersmedia.com/antiglare-glass-market-statistics-by-2019-2025-top-trends-growth-drivers/88890876

Source: MarketersMedia

Release ID: 88890876

Builders In Berkshire Home Refurbishments Loft & Garage Conversions Launched

MT Construction, a team of Master Builders in Berkshire launched home refurbishments, loft conversions, and garage conversions services for residential properties across the region. The company specializes in the cost-effective conversion of lofts and garages into lifestyle and utility areas.

Reading , United Kingdom – June 28, 2019 /PressCable/

MT Construction, a team of Master Builders in Berkshire announced the launch of home refurbishments and loft & garage conversion services. The Berkshire builders combine the latest industry best practices with time-tested construction techniques.

More information about MT Construction is available at https://www.mtconstructionltd.co.uk

Loft conversions are a popular and cost-effective renovation to create new living spaces in a home. Lofts tend to fall into disuse or have limited use as a storage area and converted lofts or garages can add significant value to a property.

Berkshire home refurbishment specialists at MT Construction are able to transform any loft, attic space, or barn into a guest room, children’s room, home gym, entertainment centre, or library.

The Reading home improvement contractor’s team of skilled tradesmen and builders can convert garages into an extra bedroom, an outhouse, or any other type of living or utility area. In-house architects gain a clear understanding of a customer’s needs and vision and translate this vision into a workable plan.

MT Construction builders conduct periodic quality checks, ensure schedule adherence, and communicate any changes or completions to a client. The team uses materials of the highest quality and ensures that all conversions and renovations are compliant with building regulations.

More information about the company’s Berkshire services is available at https://www.mtconstructionltd.co.uk/builders-in-berkshire

According to a spokesperson for the loft conversion specialists in Berkshire, “We can offer a variety of services including architectural design and planning, home improvements, and refurbishments. From small changes to single rooms to full refurbishments from the inside out, we offer a bespoke design and building service.”

MT Construction is a full-service building and refurbishment company in Reading, serving communities across Berkshire and the South of England. The company is a government-endorsed TrustMark builder and a member of the Federation of Master Builders with more than 65 years of construction and renovation experience.

More information is available by calling 012-5647-1820 or visiting the URL above.

Contact Info:
Name: Martin Thrift
Email: Send Email
Organization: MT Construction Ltd
Address: 6-8 Market Place, Reading , Berkshire RG1 2EG, United Kingdom
Phone: +44-7826-115882
Website: https://www.mtconstructionltd.co.uk/

Source: PressCable

Release ID: 88890723

Co-Packaging Market 2019 Global Key Players, Trends, Share, Industry Size, Key Developments, Opportunities, Forecast To 2025

Detailed analysis of the “Co-Packaging Market” helps to understand the various types of Interactive Tables products that are currently in use, along with the variants that would gain prominence in the future.

Pune, India – June 28, 2019 /MarketersMedia/

To know more about Co-Packaging Market Report request sample @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1826149

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Deufol, FedEx, Stamar Packaging, Unicep, Sonoco, Multi-Pack Solutions, Verst, Summit, Marsden Packaging, Cascata Packaging

Market segment by Type, the product can be split into
– Glass Containers
– Plastic Bottles
– Blister Packs
– Pouches
– Others
Market segment by Application, split into
– Food and Beverage
– Consumer Goods
– Personal Care
– Pharmaceutical
– Others

This report presents the worldwide Co-Packaging market size (value, production and consumption), splits the breakdown (data status 2014-2019 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

The food and beverages segment accounted for the major shares for the contract packaging market. Factors such as the growing urban population and the increasing demand for processed food will contribute to the growth of this industry segment in the coming years. Moreover, the growing demand from the food and beverage sector that will propel the need for packaging, will also subsequently increase the need for contract packaging in this end-user segment.

Complete report on Co-Packaging market spread across 94 pages, profiling 10 companies and supported with tables and figures is now available @ https://www.reportsnreports.com/contacts/discount.aspx?name=1826149

The Co-Packaging market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Co-Packaging.

With tables and figures helping analyze worldwide Co-Packaging market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Major Points from Table of Contents
Charpter 1 – Co-Packaging Market Overview
Charpter 2 – Global Co-Packaging Competition by Players/Suppliers, Type and Application
Charpter 3 – United States Co-Packaging (Volume, Value and Sales Price)
Charpter 4 – China Co-Packaging (Volume, Value and Sales Price)
Charpter 5- Europe Co-Packaging (Volume, Value and Sales Price)
Charpter 6 – Japan Co-Packaging (Volume, Value and Sales Price)
Charpter 7 – Southeast Asia Co-Packaging (Volume, Value and Sales Price)
Charpter 8 – India Co-Packaging (Volume, Value and Sales Price)
Charpter 9 – Global Co-Packaging Players/Suppliers Profiles and Sales Data
Charpter 10 – Co-Packaging Maufacturing Cost Analysis
Charpter 11 – Industrial Chain, Sourcing Strategy and Downstream Buyers
Charpter 12 – Marketing Strategy Analysis, Distributors/Traders
Charpter 13 – Market Effect Factors Analysis
Charpter 14 – Global Co-Packaging Market Forecast (2019-2025)
Charpter 15 – Research Findings and Conclusion
Charpter 16 – Appendix

Avail Discount on Purchase of this Report with coupon code available on the website at https://www.reportsnreports.com/purchase.aspx?name=1826149

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1826149-global-co-packaging-market-size-status-and-forecast-2019-2025.html

Source URL: https://marketersmedia.com/co-packaging-market-2019-global-key-players-trends-share-industry-size-key-developments-opportunities-forecast-to-2025/88890989

Source: MarketersMedia

Release ID: 88890989

By 2024, Protein Hydrolysate Market Value will reach USD 950 million

Protein Hydrolysate Market to witness remarkable growth during forecast period owing to increasing income levels along with shift in consumer preferences towards nutritional products.

Selbyville, United States – June 28, 2019 /MarketersMedia/

Germany protein hydrolysate market from clinical nutrition applications should exceed USD 8 million by 2024. Changing dietary patterns, over-consumption of empty calories through junk foods ensuring high risk of modern malnutrition amongst affluent population will drive product demand for clinical nutrition applications.

China protein hydrolysates market size will mainly be driven by infant nutrition application which expects significant gains at over 8% by 2024. China accounts for more than 35% of the global retail market for infant formula. In 2016, China completely scrapped its one child policy after 35 years as an active response to ageing population This political move will have positive impact on infant nutritional products demand.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2018

Moreover, rapid urbanization in China over recent years has led to greater number of women entering the workforce leading to increased disposable income. Such shifts are also impacting on the kind of infant formula being bought by parents who are increasingly demanding nutritional value and premium products for infants resulting into protein hydrolysate market growth.

Plant protein hydrolysates market size should witness gains at over 5% by 2024. Nutritional products manufacturers are considering rice, soy and wheat to substitute milk based products as a result of milk price fluctuations over the recent years. Plant protein hydrolysate should witness steady gains as consumer are preferring products derived from plants.

Global protein hydrolysate market share is competitive and moderately consolidated. Arla Foods, Frieslandcampina, Mead Johnson, Davisco and Fonterra are some companies present in this market. In November 2016. Arla foods launched four new products adding to its hydrolysate portfolio targeted for usage in RTD beverages and shake powders. This launch also included introduction of mildly hydrolyzed protein gel named as hydro gel for usage in sports nutrition.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2018

Protein hydrolysates market size from sports nutrition applications should exceed consumption of 10 kilo tons by 2024. This application should witness strongest gains in the U.S. owing to increasing popularity of RTD beverages, nutrition bars and supplements. Sports drinks and supplements were initially targeted for athletes & bodybuilders however these products are undergoing mass adoption by lifestyle and recreational users which will stimulate product demand in the region.

Growing popularity of infant foods owing to increased affordability and rising income levels should drive global protein hydrolysate market growth. Consumer acceptance regarding importance of nutrition at early stage of infancy along with strong marketing efforts from manufacturers will fuel product demand.

Browse Complete Report Summary @ https://www.gminsights.com/industry-analysis/protein-hydrolysate-market

Whey protein hydrolysate market size should surpass USD 450 million by 2024. They act as a source of amino acid which helps in reduction of various diseases such as diabetes and hence is widely used as supplement in clinical nutrition. Powder based ingredients are preferred by users over liquid due to their longer shelf life. Investment in research by manufacturers has resulted in development of new product offerings which should favor product demand.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Global Market Insights, Inc.
Website: https://www.gminsights.com/industry-analysis/protein-hydrolysate-market

Source URL: https://marketersmedia.com/by-2024-protein-hydrolysate-market-value-will-reach-usd-950-million/88890995

Source: MarketersMedia

Release ID: 88890995